MedTrace Logo

Reduced Anti-Platelet Therapy With Pimecrolimus Drug Eluting Stent (RAPID)

NCT00322543 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2008-10-17

No results posted yet for this study

Summary

Non-randomized, single arm, multi-center, clinical trial evaluating the Corio™ pimecrolimus-eluting stent with reduced anti-platelet therapy in patients with de novo lesions of the native coronary arteries.

Conditions

  • Coronary Disease

Interventions

DEVICE

Corio™ Pimecrolimus-eluting stent

Sponsors & Collaborators

  • Conor Medsystems

    lead INDUSTRY

Principal Investigators

  • Alexandre Abizaid, M.D. · Institute Dante Pazzanese of Cardiology

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-05-31
Primary Completion
2006-11-30
Completion
2008-05-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00322543 on ClinicalTrials.gov